Recruitment of BAG2 to DNAJ-PKAc scaffolds promotes cell survival and resistance to drug-induced apoptosis in fibrolamellar carcinoma
-
Published:2024-02
Issue:2
Volume:43
Page:113678
-
ISSN:2211-1247
-
Container-title:Cell Reports
-
language:en
-
Short-container-title:Cell Reports
Author:
Lauer Sophia M.,
Omar Mitchell H.,
Golkowski Martin G.,
Kenerson Heidi L.,
Lee Kyung-Soon,
Pascual Bryan C.,
Lim Huat C.,
Forbush Katherine,
Smith F. Donelson,
Gordan John D.,
Ong Shao-En,
Yeung Raymond S.,
Scott John D.ORCID
Reference108 articles.
1. Epidemiologic Research of Rare Cancers: Trends, Resources, and Challenges;Gallicchio;Cancer Epidemiol. Biomarkers Prev.,2021
2. The landscape of kinase fusions in cancer;Stransky;Nat. Commun.,2014
3. Detection of a recurrent DNAJB1-PRKACA chimeric transcript in fibrolamellar hepatocellular carcinoma;Honeyman;Science,2014
4. Defining Incidence and Complications of Fibrolamellar Liver Cancer through Tiered Computational Analysis of Clinical Data;Zack T;Nature Precision Oncology,2023
5. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database;Eggert;United European Gastroenterol. J.,2013
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献